MONTREAL, QUEBEC--(Marketwire - March 25, 2008) - Thallion Pharmaceuticals Inc. (TSX: TLN) today announced that it is hosting an analyst event in Toronto on Friday, March 28, 2008 at 9:00am ET. The event will be broadcast live via a webcast presentation accessible from the Company's website at www.thallion.com. Thallion's management team and key clinical collaborators will present an update and in-depth discussions on Thallion's three late-stage clinical programs, its oncology candidates ECO-4601 and CAP-232 as well as its infectious disease candidate Shigamabs®.
